Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Exchange Rate Effect (2020 - 2025)

Historic Exchange Rate Effect for ImmunityBio (IBRX) over the last 6 years, with Q3 2025 value amounting to -$56000.0.

  • ImmunityBio's Exchange Rate Effect fell 60909.09% to -$56000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3000.0, marking a year-over-year increase of 10697.67%. This contributed to the annual value of -$23000.0 for FY2024, which is 9212.33% up from last year.
  • As of Q3 2025, ImmunityBio's Exchange Rate Effect stood at -$56000.0, which was down 60909.09% from $76000.0 recorded in Q2 2025.
  • Over the past 5 years, ImmunityBio's Exchange Rate Effect peaked at $255000.0 during Q2 2022, and registered a low of -$254000.0 during Q1 2023.
  • In the last 5 years, ImmunityBio's Exchange Rate Effect had a median value of -$1000.0 in 2023 and averaged $1421.1.
  • In the last 5 years, ImmunityBio's Exchange Rate Effect surged by 120000.0% in 2024 and then tumbled by 60909.09% in 2025.
  • Quarter analysis of 5 years shows ImmunityBio's Exchange Rate Effect stood at $65000.0 in 2021, then surged by 147.69% to $161000.0 in 2022, then plummeted by 116.77% to -$27000.0 in 2023, then soared by 74.07% to -$7000.0 in 2024, then tumbled by 700.0% to -$56000.0 in 2025.
  • Its last three reported values are -$56000.0 in Q3 2025, $76000.0 for Q2 2025, and -$10000.0 during Q1 2025.